Hao-Jie Chen, Lei Qian, Ke Li, 等. Hydrogen sulfide-induced post-translational modification as a potential drug target[J]. Genes & Diseases, 2023,10(5).
Hao-Jie Chen, Lei Qian, Ke Li, et al. Hydrogen sulfide-induced post-translational modification as a potential drug target[J]. Genes & Diseases, 2023,10(5).
Hao-Jie Chen, Lei Qian, Ke Li, 等. Hydrogen sulfide-induced post-translational modification as a potential drug target[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.03.022.
Hao-Jie Chen, Lei Qian, Ke Li, et al. Hydrogen sulfide-induced post-translational modification as a potential drug target[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.03.022.
Hydrogen sulfide-induced post-translational modification as a potential drug target
摘要
Abstract
Hydrogen sulfide (H
2
S) is one of the three known gas signal transducers
and since its potential physiological role was reported
the literature on H
2
S has been increasing. H
2
S is involved in processes such as vasodilation
neurotransmission
angiogenesis
inflammation
and the prevention of ischemia-reperfusion injury
and its mechanism remains to be further studied. At present
the role of post-translational processing of proteins has been considered as a possible mechanism for the involvement of H
2
S in a variety of physiological processes. Current studies have shown that H
2
S is involved in S-sulfhydration
phosphorylation
and S-nitrosylation of proteins
etc. This paper focuses on the effects of protein modification involving H
2
S on physiological and pathological processes
looking forward to providing guidance for subsequent research.